Skip to content

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
3.2×+0.4×
Opko Health logo
Opko HealthOPK
0.2×-0.3×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
3.8×-2.3×
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
6.1×+1.1×
Erasca, Inc. logo
Erasca, Inc.ERAS
1.8×-1.0×

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Calculated from Olema Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s cash ratio?
Olema Pharmaceuticals, Inc. (OLMA) reported cash ratio of 1.1× in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s cash ratio changed year-over-year?
Olema Pharmaceuticals, Inc.'s cash ratio decreased by 42.7% year-over-year, from 1.9× to 1.1×.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s cash ratio has grown at a -58.3% compound annual growth rate (CAGR), from 73.8× to 0.9×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.